GW Pharmaceuticals innovative business update replaces interim statement
19/07/2007
In response to recent changes stipulating companies are no longer required to produce a printed interim report, GW Pharmaceuticals' maintains communication with shareholders through an innovative high impact mailer in the form of an A5 poster produced by Emperor. The document is unique in its size and contains a broad range of information covering Company highlights, a progress report from the Chairman and Managing Director combined with colourful diagrams and tables outlining strategy, markets and partnerships. This mailer is a powerful piece of communication that can be used to replace the interim statement.